An understanding of science in this the 21st century is an essential ingredient for leading a productive and rewarding life.
Friday, March 17, 2017
Tuesday, March 14, 2017
Strategy for the Preferential Elimination of Cancer Cells
The cell surface of mammalian cells is populated with a wide array of proteins that are involved in many aspects of cell-cell communication that is absolutely essential for life. When a normal tissue cell is transformed into a cancerous cell, it often exhibits proteins on the surface that indicate that it has become aberrant – no longer subject to the usual controls that inhibit unrestrained growth.
These “marker” proteins are frequently used to identify cancerous cells and therapeutic strategies are being studied to exploit the presence of these proteins to preferentially kill tumor cells. However, in some types of cancer no unique markers are identifiable.
In order to circumvent this obstacle, Zhiyu Wang from the University of Illinois recently reported on a methodology to positively identify cancer cells that relies on a different approach. Their research strategy can be described in the following way.
They incubated tumor cultured cells with a class of compounds called sugar azides (structure shown below). The compound DBCO (structure shown below) binds preferentially to sugar azide on the cell surface. In order to ensure that the sugar azide appears only on cancer cells, the researchers modified the sugar azide with protective group that could only be removed with an intracellular tumor-specific enzyme. Once the DBCO-sugar azide complex is on the cell surface, it can be exploited to deliver cancer treating drugs or agents that can used to provide important imaging information.
These “marker” proteins are frequently used to identify cancerous cells and therapeutic strategies are being studied to exploit the presence of these proteins to preferentially kill tumor cells. However, in some types of cancer no unique markers are identifiable.
In order to circumvent this obstacle, Zhiyu Wang from the University of Illinois recently reported on a methodology to positively identify cancer cells that relies on a different approach. Their research strategy can be described in the following way.
They incubated tumor cultured cells with a class of compounds called sugar azides (structure shown below). The compound DBCO (structure shown below) binds preferentially to sugar azide on the cell surface. In order to ensure that the sugar azide appears only on cancer cells, the researchers modified the sugar azide with protective group that could only be removed with an intracellular tumor-specific enzyme. Once the DBCO-sugar azide complex is on the cell surface, it can be exploited to deliver cancer treating drugs or agents that can used to provide important imaging information.
Tuesday, February 21, 2017
The Metabolic Syndrome
The metabolic syndrome refers to that constellation of risk
factors that increase the likelihood of such potentially life-threatening
conditions as coronary heart disease (CHD), stroke and diabetes. It is now estimated that some forty-seven
million individuals currently suffer from metabolic syndrome within the United
States. The size of this at-risk
population is a cause for concern from a public health perspective. On account of the fact that this population
is growing strongly suggest that there are environmental factors involved and
that need to be explored.
The five conditions enumerated below are referred to as metabolic
risk factors and they are -
- · “A large waistline. This also is called abdominal obesity. Excess fat in the stomach area is a greater risk factor for heart disease than excess fat in other parts of the body, such as on the hips.
- · A high triglyceride level (or you're on medicine to treat high triglycerides). Triglycerides are a type of fat found in the blood.
- · A low HDL cholesterol level (or you're on medicine to treat low HDL cholesterol). HDL sometimes is called "good" cholesterol. This is because it helps remove cholesterol from your arteries. A low HDL cholesterol level raises your risk for heart disease.
- · High blood pressure (or you're on medicine to treat high blood pressure). Blood pressure is the force of blood pushing against the walls of your arteries as your heart pumps blood. If this pressure rises and stays high over time, it can damage your heart and lead to plaque buildup.
- · High fasting blood sugar (or you're on medicine to treat high blood sugar). Mildly high blood sugar may be an early sign of diabetes.”
The projected risk for heart disease, diabetes, and stroke
increases with the number of metabolic risk factors presented. The risk of
having metabolic syndrome is also closely linked to obesity and a lack of
physical activity.
Insulin resistance is a definitive risk factor for the
metabolic syndrome and is strongly associated with Type II Diabetes. Insulin is the small protein hormone produced
by specialized cells of the pancreas (Islets of Langerhans). Insulin (see image below) is produced in
response to the presence of elevated glucose in the blood – usually following a
meal – and is responsible for regulating glucose levels in the blood. Insulin resistance refers to that condition
in which the body fails to use this hormone properly.
Structure of Human Insulin
Tuesday, January 17, 2017
Human Pancreatic Cancer and CD155 Expression
The cell surface transmembrane glycoprotein CD 155 is expressed in many different human tissue cells. This protein has also been shown to be expressed in pancreatic cells in patients suffering from pancreatic cancer. CD 155 is also referred to as a poliovirus receptor (PVR) on account of the fact that it has been implicated in infection with poliovirus in the primate animal model. Current evidence suggests that its function within normal cells is associated with maintaining cohesion between epithelial cells.
S. Nishiwada and his colleagues from the Department of Surgery, Nara Medical University in Kashihara Nara, Japapn have put considerable effort into the study of the role CD 155 expression in human pancreatic cancer within a clinical setting.
In their study of 134 patients with pancreatic cancer, they found that those patients that demonstrated high levels of CD 155 expression also showed a poorer postoperative prognosis than those with low expression of this protein. In addition, they have found an inverse relationship between the expression of CD 155 and the body’s ability to dispatch tumor-infiltrating lymphocytes to the site of the tumor in order to destroy cancerous cells. Furthermore, expression of CD 155 positively correlated with increased growth of the malignancy and angiogenesis – growth of new blood vessels towards the growing tumor. Both of these effects enhances tumor growth. As would be expected, suppression of CD 155 expression, inhibited cell division within pancreatic cancer cells.
Given these important findings, CD 155 may prove to be an important target in pancreatic cancer therapy.
S. Nishiwada and his colleagues from the Department of Surgery, Nara Medical University in Kashihara Nara, Japapn have put considerable effort into the study of the role CD 155 expression in human pancreatic cancer within a clinical setting.
In their study of 134 patients with pancreatic cancer, they found that those patients that demonstrated high levels of CD 155 expression also showed a poorer postoperative prognosis than those with low expression of this protein. In addition, they have found an inverse relationship between the expression of CD 155 and the body’s ability to dispatch tumor-infiltrating lymphocytes to the site of the tumor in order to destroy cancerous cells. Furthermore, expression of CD 155 positively correlated with increased growth of the malignancy and angiogenesis – growth of new blood vessels towards the growing tumor. Both of these effects enhances tumor growth. As would be expected, suppression of CD 155 expression, inhibited cell division within pancreatic cancer cells.
Given these important findings, CD 155 may prove to be an important target in pancreatic cancer therapy.
Monday, December 19, 2016
Plasma Membrane Compartments and Cytokine Signaling
The cell (plasma) membrane is a complex array of lipids and
proteins that plays an essential role in the communication between the cell and
its external environment (see image below).
In complex multi-cellular organisms, individual tissue cells communicate
with vast varieties of factors including hormones and cytokines that are found
in the tissue fluids that bathe cells and within the circulatory system that
delivers nutrients to these cells.
Cytokines are a special class of compounds including
interferon (IFN) (see structure below) and interleukins. These substances are low molecular weight
proteins often bound to sugar molecules (glycoproteins) that promote cell to
cell communication within the immune system in response to inflammation,
infectious agents and trauma.
Interferon
Changiiang You and his colleagues from *the Universitat
Osnabruck, Germany, studied in detail the interaction dynamics of the complex
array of signaling components and receptors on the plasma membrane especially
in regard to IFN. Interferons augment
the immune system response to viral infections and impede the growth of cancerous
cells through the regulation of specific genes whose gene products impact cell
growth.
The results of their extensive investigation demonstrated that
microcompartmentalization plays an essential role in facilitating binding of IFN
to its specific receptor on the plasma membrane and the resulting cascade of
signaling events that leads to gene expression (see image below). They found that the maintenance of the
integrity of the membrane skeleton (MSK) is of crucial importance.
These finding are of value; because, they help elucidate the complex interactions that are required to insure the successful role of key factors like interferon in proper cell function.
Monday, November 21, 2016
Site Specific Phosphorylation of Tau Inhibits Alzheimer’s in Mice
Alzheimer’s disease impacts many individuals in the latter
stages of life. It is a form of dementia
that is very devastating to the individuals affected and their families. On the molecular level, the disease is
indicated by extracellular protein “plaques” that are composed of amyloid-β
(Aβ) and an accumulation of so-called, “neurofibrillary tangles” within the
neurons (see images below). These
tangles are composed of tau protein. Amyloids
represent aggregates of proteins that are stuck together and pose problems for
cellular health and development in tissues.
This is especially important within the central nervous system since
communication between neurons is of such vital importance.
The accumulated evidence suggests that it is the combined
impact of Aβ and tau that lead to the neuronal dysfunction that is indicated by
the severe cognitive deficits exhibited by individual with this disease. Furthermore, the production of Aβ seems to
trigger the subsequent phosphorylation of tau protein that lead to its
deposition and ultimately to cognitive deficits. In mouse animal models, the depletion of tau
prevents Aβ toxicity. It seems that by
the time the symptoms are evident, significant cell damage has already occurred.
However, recent studies by Dr. Arne Ittner and his
colleagues from the School of Medical Sciences at UNSW Australia have shown
that site-specific phosphorylation of tau directed by the neuronal p38
mitogen-activated protein kinase enzyme (p38γ) actually inhibited Aβ
toxicity. Furthermore, the depletion of p38γ
worsened cognitive defects and increasing p38γ eliminated these deficits.
These results are of importance; for, they demonstrate that
phosphorylation of tau may or may not be detrimental depending upon the site(s)
on the protein structure that are impacted.
Saturday, November 5, 2016
The Impact of Climate Change on Desertification
Climate Change and Desertification - The following is a link to an extensive New York Times article regarding the expansion of the Tengger desert in China and the impact of this change on the affected population -
Subscribe to:
Posts (Atom)









